E-LIB Suche - Ergebnisse für: Manvelian, Garen

1

Effect of proprotein convertase subtilisin/kexin type 9 inh..:

Mohammadi, Kusha A ; Brackin, Taylor ; Schwartz, Gregory G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501297/. , 2023

Link: http://www.ncbi.nlm.nih...

2

Effect of alirocumab on cataracts in patients with acute co..:

Suc, Gaspard ; Schwartz, Gregory G ; Goodman, Shaun G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276414/. , 2023

Link: http://www.ncbi.nlm.nih...

3

Long‐Term Efficacy, Safety, and Tolerability of Alirocumab ..:

Goodman, Shaun G ; Steg, Philippe Gabriel ; Poulouin, Yann...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547267/. , 2023

Link: http://www.ncbi.nlm.nih...

4

Correction: Effect of alirocumab on cataracts in patients w..:

Suc, Gaspard ; Schwartz, Gregory G ; Goodman, Shaun G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324219/. , 2023

Link: http://www.ncbi.nlm.nih...

5

Apolipoprotein B, Residual Cardiovascular Risk After Acute ..:

Hagström, Emil ; Steg, P Gabriel ; Szarek, Michael...
https://pure.au.dk/portal/da/publications/apolipoprotein-b-residual-cardiovascular-risk-after-acute-coronary-syndrome-and-effects-of-alirocumab(2f78bf21-2729-4f72-b0a6-e98aabbc4f9c).html. , 2022

Link: https://pure.au.dk/porta..

6

Apolipoprotein B, Residual Cardiovascular Risk After Acute ..:

Hagström, Emil ; Steg, P Gabriel ; Szarek, Michael...
qt7z59p110. , 2022

Link: https://escholarship.org..

7

Apolipoprotein B, Residual Cardiovascular Risk After Acute ..:

Hagström, Emil ; Steg, P. Gabriel ; Szarek, Michael...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422774/. , 2022

Link: http://www.ncbi.nlm.nih...

8

Efficacy and Safety of Alirocumab in Children and Adolescen..:

Bruckert, Eric ; Caprio, Sonia ; Wiegman, Albert...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750107/. , 2022

Link: http://www.ncbi.nlm.nih...

9

Apolipoprotein B, Residual Cardiovascular Risk After Acute ..:

Hagström, Emil ; Steg, P. Gabriel ; Szarek, Michael...
Circulation, 0009-7322, 2022, 146:9, s. 657-672. , 2022

Link: http://urn.kb.se/resolve..

10

Apolipoprotein B, Residual Cardiovascular Risk After Acute ..:

Hagström, Emil ; Steg, P. Gabriel ; Liberopoulos, Evangelos...
info:eu-repo/semantics/altIdentifier/issn/0009-7322. , 2022

Link: https://publications.rwt..

11

Apolipoprotein B, Residual Cardiovascular Risk After Acute ..:

Hagström, Emil ; Steg, P Gabriel ; Szarek, Michael...
info:eu-repo/semantics/altIdentifier/doi/10.1161/CIRCULATIONAHA.121.057807. , 2022

Link: https://repository.vu.lt..

12

Pharmacogenomic Study of Statin-Associated Muscle Symptoms ..:

Murphy, William A ; Lin, Nan ; Damask, Amy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213083/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients ..:

Schwartz, Gregory G ; Szarek, Michael ; Bittner, Vera A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822604/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients ..:

Schwartz, Gregory G ; Szarek, Michael ; Bittner, Vera A...
433. , 2021

Link: https://repositorio.udes..

15

Treatment adherence and effect of concurrent statin intensi..:

Banach, Maciej ; López-Sendon, José Luis ; Averna, Maurizio...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924821/. , 2021

Link: http://www.ncbi.nlm.nih...